| Bryon M Geer, DO | |
|
2700 Wayne Memorial Dr, Emergency Room, Goldsboro, NC 27534-9494 | |
| (919) 731-6060 | |
| (919) 731-6534 |
| Full Name | Bryon M Geer |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 20 Years |
| Location | 2700 Wayne Memorial Dr, Goldsboro, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942426507 | NPI | - | NPPES |
| 200700229 | Other | NC | LICENSE |
| 145HV | Other | BLUE CROSS BLUE SHIELD | |
| 89145HV | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207PE0004X | Emergency Medicine - Emergency Medical Services | 200700229 (North Carolina) | Secondary |
| 207P00000X | Emergency Medicine | 200700229 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wayne Memorial Hospital | Goldsboro, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mt Olive Family Medicine Center Inc | 3870547227 | 11 |
| Goldsboro Emergency Medical Specialists Inc | 5294633293 | 12 |
| Immediate Care Of Goldsboro Pllc | 5991603979 | 14 |
News Archive
Meaningful and lasting progress in addressing global health challenges cannot be achieved without partnerships and collaboration, according to a publication released today, Case Studies for Global Health.
Excaliard Pharmaceuticals, Inc. announced today the initiation of three proof of concept Phase 2 trials of EXC 001, an antisense medicine that reduces fibrosis, for the amelioration of skin scarring and other fibrotic disorders.
The plot of many a science fiction TV series or movie revolves around the premise that people traveling long distances in space age more slowly than their counterparts on Earth. Now, tiny worms who spent time aboard the International Space Station could help humans understand more about the effects of aging in space for real.
Beyond vaccination, the broad-spectrum antiviral medication remdesivir has robust clinical evidence and is known as the best antiviral treatment to reduce severe COVID-19 infection in hospitalized patients. Research led by John F.X. Diffley of the Chromosome Replication Laboratory suggests a potential therapeutic target for treatment development is the viral RNA cap methyltransferases, essential for viral protein translation and immune evasion.
› Verified 7 days ago
| Entity Name | Immediate Care Of Goldsboro Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952397028 PECOS PAC ID: 5991603979 Enrollment ID: O20031229000769 |
News Archive
Meaningful and lasting progress in addressing global health challenges cannot be achieved without partnerships and collaboration, according to a publication released today, Case Studies for Global Health.
Excaliard Pharmaceuticals, Inc. announced today the initiation of three proof of concept Phase 2 trials of EXC 001, an antisense medicine that reduces fibrosis, for the amelioration of skin scarring and other fibrotic disorders.
The plot of many a science fiction TV series or movie revolves around the premise that people traveling long distances in space age more slowly than their counterparts on Earth. Now, tiny worms who spent time aboard the International Space Station could help humans understand more about the effects of aging in space for real.
Beyond vaccination, the broad-spectrum antiviral medication remdesivir has robust clinical evidence and is known as the best antiviral treatment to reduce severe COVID-19 infection in hospitalized patients. Research led by John F.X. Diffley of the Chromosome Replication Laboratory suggests a potential therapeutic target for treatment development is the viral RNA cap methyltransferases, essential for viral protein translation and immune evasion.
› Verified 7 days ago
| Entity Name | Goldsboro Emergency Medical Specialists Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164418232 PECOS PAC ID: 5294633293 Enrollment ID: O20031229000879 |
News Archive
Meaningful and lasting progress in addressing global health challenges cannot be achieved without partnerships and collaboration, according to a publication released today, Case Studies for Global Health.
Excaliard Pharmaceuticals, Inc. announced today the initiation of three proof of concept Phase 2 trials of EXC 001, an antisense medicine that reduces fibrosis, for the amelioration of skin scarring and other fibrotic disorders.
The plot of many a science fiction TV series or movie revolves around the premise that people traveling long distances in space age more slowly than their counterparts on Earth. Now, tiny worms who spent time aboard the International Space Station could help humans understand more about the effects of aging in space for real.
Beyond vaccination, the broad-spectrum antiviral medication remdesivir has robust clinical evidence and is known as the best antiviral treatment to reduce severe COVID-19 infection in hospitalized patients. Research led by John F.X. Diffley of the Chromosome Replication Laboratory suggests a potential therapeutic target for treatment development is the viral RNA cap methyltransferases, essential for viral protein translation and immune evasion.
› Verified 7 days ago
| Entity Name | Mt Olive Family Medicine Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467481762 PECOS PAC ID: 3870547227 Enrollment ID: O20050310000798 |
News Archive
Meaningful and lasting progress in addressing global health challenges cannot be achieved without partnerships and collaboration, according to a publication released today, Case Studies for Global Health.
Excaliard Pharmaceuticals, Inc. announced today the initiation of three proof of concept Phase 2 trials of EXC 001, an antisense medicine that reduces fibrosis, for the amelioration of skin scarring and other fibrotic disorders.
The plot of many a science fiction TV series or movie revolves around the premise that people traveling long distances in space age more slowly than their counterparts on Earth. Now, tiny worms who spent time aboard the International Space Station could help humans understand more about the effects of aging in space for real.
Beyond vaccination, the broad-spectrum antiviral medication remdesivir has robust clinical evidence and is known as the best antiviral treatment to reduce severe COVID-19 infection in hospitalized patients. Research led by John F.X. Diffley of the Chromosome Replication Laboratory suggests a potential therapeutic target for treatment development is the viral RNA cap methyltransferases, essential for viral protein translation and immune evasion.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bryon M Geer, DO Po Box K, Goldsboro, NC 27533-9710 Ph: (919) 731-6060 | Bryon M Geer, DO 2700 Wayne Memorial Dr, Emergency Room, Goldsboro, NC 27534-9494 Ph: (919) 731-6060 |
News Archive
Meaningful and lasting progress in addressing global health challenges cannot be achieved without partnerships and collaboration, according to a publication released today, Case Studies for Global Health.
Excaliard Pharmaceuticals, Inc. announced today the initiation of three proof of concept Phase 2 trials of EXC 001, an antisense medicine that reduces fibrosis, for the amelioration of skin scarring and other fibrotic disorders.
The plot of many a science fiction TV series or movie revolves around the premise that people traveling long distances in space age more slowly than their counterparts on Earth. Now, tiny worms who spent time aboard the International Space Station could help humans understand more about the effects of aging in space for real.
Beyond vaccination, the broad-spectrum antiviral medication remdesivir has robust clinical evidence and is known as the best antiviral treatment to reduce severe COVID-19 infection in hospitalized patients. Research led by John F.X. Diffley of the Chromosome Replication Laboratory suggests a potential therapeutic target for treatment development is the viral RNA cap methyltransferases, essential for viral protein translation and immune evasion.
› Verified 7 days ago
Dr. Craig Alan Soltis, M. D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 Wayne Memorial Dr, Goldsboro, NC 27534 Phone: 919-731-6060 Fax: 919-580-9224 | |
Dr. Daniel Lowell Drotts, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 Wayne Memorial Dr, Emergency Dept, Goldsboro, NC 27534 Phone: 919-731-6060 Fax: 919-731-6534 | |
Dr. Frederick L Potts, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2700 Wayne Memorial Dr, Emergency Dept, Goldsboro, NC 27534 Phone: 919-731-6060 Fax: 919-580-9224 | |
Dr. Israel Landa, M.D Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 Wayne Memorial Drive, Emergency Department, Goldsboro, NC 27534 Phone: 919-731-6060 Fax: 919-731-6534 | |
James D Salisbury, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 Wayne Memorial Dr, Goldsboro, NC 27534 Phone: 919-731-6060 | |
Dr. Lloyd Hamlin Smith, M. D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 Wayne Memorial Dr, Goldsboro, NC 27534 Phone: 919-731-6060 Fax: 919-580-9224 | |
Sidney B Mccall, PARAMEDIC Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 817 N Spence Ave, Goldsboro, NC 27534 Phone: 919-687-6004 |